Frank A. Giordano: CXCL12 and VEGF Inhibition Glioblastoma
Frank A. Giordano, Chair Deptartement of Radiation Oncology at University Medical Center Mannheim, shared on LinkedIn:
“Glioblastoma remains one of the most challenging cancers to treat. Our latest research focuses on blocking CXCL12 and VEGF. By inhibiting both, we’re seeing promising advancements in improving patient outcomes and offering new hope in a space where effective treatments are critically needed.
It’s incredible to be part of a fantastic team pushing the boundaries in brain cancer care: Thank you Julian Layer, Michael Hölzel, Nils Nicolay, Clemens Seidel, Ghazaleh Tabatabai, Sonia Leonardelli, Elena Sperk, Michael Platten, Sotirios Bisdas, Sied Kebir and TME Pharma for all your support and your continuous trust in us.”
Source: Frank A. Giordano/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023